Ophthalmology Times Europe
SEARCH
  • home
  • about us
  • contact us
  • subscribe
  • media kit request
 

CATARACT

GLAUCOMA

REFRACTIVE

RETINA

Previous StoryPlay / PauseNext Story
Latest retina news
Alcon drops AMD candidate
July 21, 2008
Following disappointing clinical trial results, Alcon has discontinued its plans to develop anecortave acetate for the prevention of choroidal neovascularization secondary to age-related macular degeneration (AMD).
Chemotherapy can save eyes
July 21, 2008
A direct ophthalmic artery infusion of melphalan for retinoblastoma can enable eyes designated as enucleated to be salvaged, according to a study published in the July 2008 issue of Ophthalmology.
Geuder discusses new products
July 21, 2008
Geuder Group discussed several new products, including Brilliant Peel vitreoretinal fluid dye and Siluron 2000, during a posterior segment symposium at this year's Euretina meeting.
DR not main cause of blindness in diabetics
July 14, 2008
Diabetic retinopathy (DR) is not the leading cause of ocular co-morbidity in diabetic subjects, according to a study published in the June 2008 issue of the British Journal of Ophthalmology.
Nutraceutical helps patient see clearly
July 14, 2008
Longevinex (Resveratrol), a nutraceutical matrix, can remove lipofuscin deposits from the retina to improve visual acuity and night vision, according to research presented at this year's meeting of the American Academy of Optometry in Seattle, US.
Retina articles
Fundus autofluorescence imaging betters armamentarium
June 25, 2008
Fundus autofluorescence imaging, one of the modes available in a new instrument (Spectralis HRA+OCT, Heidelberg Engineering), enhances its utility as a diagnostic device and a tool for monitoring therapy of patients with retinal and macular diseases.
Combination therapies for AMD pose an intriguing avenue for research
June 18, 2008
The Verteporfin Intravitreal Triamcinolone Acetonide Study (VERITAS) of intravitreal triamcinolone acetonide (Kenalog, Bristol-Myers Squibb) or pegaptanib (Macugen, Pfizer) in combination with photodynamic therapy (PDT) with verteporfin (Visudyne, Novartis Pharmaceuticals) was underpowered to reach definitive conclusions about the therapies.
Can statins treat AMD effectively?
May 1, 2008
At present, there is no effective early-stage treatment for AMD or for arresting its progression in the early phases.
Fewer retreatments with combination AMD therapy
May 1, 2008
Providing patients with renewed hope and the chance of halting and maybe even reversing vision loss, the launch of this anti-VEGF therapy has signalled a permanent change in the way this debilitating disorder is treated worldwide.
Reducing the burden of anti-VEGF therapy follow-up appointments
May 1, 2008
All of the excitement surrounding anti-VEGF therapy has been countered slightly by one major issue: the regular treatment and follow-up regimen associated with the new class of treatments.
Eye spy
Retina journal
A Randomized Trial Comparing Intravitreal Triamcinolone and Focal/Grid Photocoagulation for Diabetic Macular Edema: Baseline Features.
Primary Repair of Retinal Detachment With 25-Gauge Pars Plana Vitrectomy.
Hypotony After 25-Gauge Vitrectomy Using Oblique Versus Direct Cannula Insertions in Fluid-Filled Eyes.
Sutureless Combined 25-Gauge Vitrectomy, Phacoemulsification, and Posterior Chamber Intraocular Lens Implantation for Management of Uveitic Cataract Associated With Posterior Segment Disease.
25-Gauge Vitrectomy and Triamcinolone Acetonide-Assisted Internal Limiting Membrane Peeling for Chronic Cystoid Macular Edema Associated With Branch Retinal Vein Occlusion.
Newsletter sign-up
AMD Practice Management: part 1
Practice management in the era of Anti-VEGF: Part 1
AMD Practice Management: part 2
Practice management in the era of anti-VEGF: Part 2
Survey
Do you use intracameral antibiotics in all of your cataract surgeries?
Always
Never
Sometimes
Rarely
Always
55%
Never
18%
Sometimes
23%
Rarely
5%
View Results
Thank you!
Call for papers

Click here to discover how you can have your say

Click here